BioCryst Pharma (BCRX) Update on Strategy, Pipeline and Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 7.56 -0.22 (2.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.78 | 52 Week High | $10.98 | |||
| Open | $7.71 | 52 Week Low | $1.63 | |||
| Day High | $7.76 | P/E | N/A | |||
| Day Low | $7.56 | EPS | $-0.68 | |||
| Volume | 187,432 | |||||
| Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) | Delayed: 0.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $4.42 | |||
| Open | $152.77 | 52 Week Low | $1.19 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.43 | EPS | $-0.64 | |||
| Volume | 14,006 | |||||
